Loading organizations...
Loading organizations...
Biotechnology company developing engineered IgM antibodies for therapies.
IGM Biosciences has raised $102.0M across 1 funding round.
IGM Biosciences has raised $102.0M in total across 1 funding round.
IGM Biosciences has raised $102.0M in total across 1 funding round.
IGM Biosciences's investors include Haldor Topsoe Holding, Janus Henderson Investors, Redmile Group, Vivo Capital.
IGM Biosciences has raised $102.0M across 1 funding round. Most recently, it raised $102.0M Series C in July 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 8, 2019 | $102.0M Series C | Haldor Topsoe Holding, Janus Henderson Investors, Redmile Group, Vivo Capital |